PAD Profile : Theophylline - Asthma

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Theophylline - Asthma

PAD Profile : Theophylline - Asthma Important

Keywords :

respiratory, asthmatics, bronchodilators

Brand Names Include :

Uniphyllin continus, Slo-phyllin, Neulin SA

Important Information :

Place in therapy under review. Therapeutic drug monitoring required. Not recommended for primary care initiation without specialist advice.

Traffic Light Status

Status 1 of 1.

Status :

See narrative

Formulations :

Modified release tablets

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

Comments :

No comments returned.

Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type

Document

Review Date

Guidelines (Local)

Asthma Guidelines - April 2019 (updated Nov 22)

01 January 2024

Guidelines (National)

NICE NG80 - Asthma-diagnosis-monitoring-and-chronic-asthma-management

Committee Recommendations

Date

Committee Name

Narrative

06 November 2024

Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The place in therapy of theophylline MR is under review. The role of theophylline in the management of asthma and COPD has changed and become much more limited now that more effective, and safer treatments are available. Therapeutic drug monitoring is required in patients on theophylline, which further limits its usefulness. Recent national guidance emphasises the need for organisations to ensure they have management systems in place to support the safe use of this medicine. It is not recommended that GPs initiate theophylline in primary care without seeking specialist advice.

Associated BNF Codes

03. Respiratory System

03.01.03. Theophylline